Case study: pembrolizumab

Researchers have highlighted a case where this newly listed medication led to drug‐induced autoimmune diabetes mellitus and colitis Pharmacist Nikhil Singh from the Royal Melbourne Hospital has shared a case study that highlights the potential for serious adverse events associated with pembrolizumab (Keytruda). In the Journal of Pharmacy Practice and Research, published by the SHPA,